Clinical implications of Brief Psychiatric Rating Scale scores

Br J Psychiatry. 2005 Oct:187:366-71. doi: 10.1192/bjp.187.4.366.

Abstract

Background: Despite the widespread use of the Brief Psychiatric Rating Scale (BPRS), the clinical meaning of its total score and cut-off values used to define treatment response are unclear.

Aims: To link the BPRS to Clinical Global Impression (CGI) ratings.

Method: Equipercentile linking of BPRS and CGI ratings from seven drug trials in acutely ill patients with schizophrenia (n=1979).

Results: 'Mildly ill' according to the CGI approximately corresponded to a BPRS total score of 31, 'moderately ill'to a BPRS score of 41 and'markedly ill'to a BPRS score of 53.'Minimally improved'according to the CGI score was associated with percentage BPRS reductions of 24, 27 and 30% at weeks 1, 2 and 4, respectively. The corresponding numbers for a CGI rating of 'much improved' were 44, 53 and 58%.

Conclusions: The results provide a clearer understanding of how to interpret BPRS total and percentage reduction scores in clinical trials with patients acutely ill with schizophrenia who are experiencing positive symptoms.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute Disease
  • Adult
  • Amisulpride
  • Antipsychotic Agents / therapeutic use
  • Benzodiazepines / therapeutic use
  • Female
  • Humans
  • Male
  • Olanzapine
  • Psychiatric Status Rating Scales* / statistics & numerical data
  • Schizophrenia / drug therapy*
  • Severity of Illness Index
  • Sulpiride / analogs & derivatives
  • Sulpiride / therapeutic use
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Benzodiazepines
  • Sulpiride
  • Amisulpride
  • Olanzapine